Antioxidant and nephroprotective activities of the extract and fractions of Homonoia riparia Lour

Seena Xavier, Shoja Haneefa, Devkar Anand, Picheswara Polo, Rajalekshmi Maheshwari, Chandrashekara Shreedhara, Manganahalli Setty

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Homonoia riparia is a plant, which is widely used in the indigenous system of medicine for the treatment of urolithiasis, renal disorders and inflammatory conditions. This is the first report on the antioxidant and nephroprotective activities of whole plant of H. riparia. Objective: The present study aims at investigating the in vitro antioxidant and nephroprotective activity of the methanol extract and its different fractions of H. riparia. Methods: Petroleum ether (HRPE), Ethyl acetate (HREA), Butanol (HRBU), aqueous fractions (HRAQ) were prepared from the crude methanol extract of H. riparia (HRM) using liquid partitioning. Total phenolic content, flavonoid content and antioxidant activity assay were performed according to suitable methods. Nephroprotective activities were evaluated by MTT assay using Human Embryonic Kidney cells against cisplatin induced toxicity. Quantification of gallic acid was performed using validated HPTLC method. Results: The studies showed that extract and fractions possess significant nephroprotective activity against cisplatin induced renal toxicity. All the extracts/fractions of whole plant of Homonoia riparia was found to be significantly reducing cisplatin induced toxicity (< 0.05). The highest activity was observed with HRBU and HRAQ with a percentage viability of 293.09 ± 4.3 and 345.07 ± 3.2 at a concentration of 200 μg/ml. Gallic acid was detected in the HRM/fractions using HPTLC.

Original languageEnglish
Pages (from-to)25-30
Number of pages6
JournalPharmacognosy Magazine
Volume13
Issue number49
DOIs
Publication statusPublished - 01-01-2017

Fingerprint

Cisplatin
Gallic Acid
Butanols
Antioxidants
Kidney
Methanol
Urolithiasis
Traditional Medicine
Systems Analysis
Complex Mixtures
Flavonoids
Therapeutics
In Vitro Techniques
naphtha
ethyl acetate

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science
  • Drug Discovery

Cite this

Xavier, Seena ; Haneefa, Shoja ; Anand, Devkar ; Polo, Picheswara ; Maheshwari, Rajalekshmi ; Shreedhara, Chandrashekara ; Setty, Manganahalli. / Antioxidant and nephroprotective activities of the extract and fractions of Homonoia riparia Lour. In: Pharmacognosy Magazine. 2017 ; Vol. 13, No. 49. pp. 25-30.
@article{e60c3b0a4e0a43c7af9a72eb135b0a0e,
title = "Antioxidant and nephroprotective activities of the extract and fractions of Homonoia riparia Lour",
abstract = "Background: Homonoia riparia is a plant, which is widely used in the indigenous system of medicine for the treatment of urolithiasis, renal disorders and inflammatory conditions. This is the first report on the antioxidant and nephroprotective activities of whole plant of H. riparia. Objective: The present study aims at investigating the in vitro antioxidant and nephroprotective activity of the methanol extract and its different fractions of H. riparia. Methods: Petroleum ether (HRPE), Ethyl acetate (HREA), Butanol (HRBU), aqueous fractions (HRAQ) were prepared from the crude methanol extract of H. riparia (HRM) using liquid partitioning. Total phenolic content, flavonoid content and antioxidant activity assay were performed according to suitable methods. Nephroprotective activities were evaluated by MTT assay using Human Embryonic Kidney cells against cisplatin induced toxicity. Quantification of gallic acid was performed using validated HPTLC method. Results: The studies showed that extract and fractions possess significant nephroprotective activity against cisplatin induced renal toxicity. All the extracts/fractions of whole plant of Homonoia riparia was found to be significantly reducing cisplatin induced toxicity (< 0.05). The highest activity was observed with HRBU and HRAQ with a percentage viability of 293.09 ± 4.3 and 345.07 ± 3.2 at a concentration of 200 μg/ml. Gallic acid was detected in the HRM/fractions using HPTLC.",
author = "Seena Xavier and Shoja Haneefa and Devkar Anand and Picheswara Polo and Rajalekshmi Maheshwari and Chandrashekara Shreedhara and Manganahalli Setty",
year = "2017",
month = "1",
day = "1",
doi = "10.4103/0973-1296.197647",
language = "English",
volume = "13",
pages = "25--30",
journal = "Pharmacognosy Magazine",
issn = "0973-1296",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "49",

}

Antioxidant and nephroprotective activities of the extract and fractions of Homonoia riparia Lour. / Xavier, Seena; Haneefa, Shoja; Anand, Devkar; Polo, Picheswara; Maheshwari, Rajalekshmi; Shreedhara, Chandrashekara; Setty, Manganahalli.

In: Pharmacognosy Magazine, Vol. 13, No. 49, 01.01.2017, p. 25-30.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Antioxidant and nephroprotective activities of the extract and fractions of Homonoia riparia Lour

AU - Xavier, Seena

AU - Haneefa, Shoja

AU - Anand, Devkar

AU - Polo, Picheswara

AU - Maheshwari, Rajalekshmi

AU - Shreedhara, Chandrashekara

AU - Setty, Manganahalli

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Background: Homonoia riparia is a plant, which is widely used in the indigenous system of medicine for the treatment of urolithiasis, renal disorders and inflammatory conditions. This is the first report on the antioxidant and nephroprotective activities of whole plant of H. riparia. Objective: The present study aims at investigating the in vitro antioxidant and nephroprotective activity of the methanol extract and its different fractions of H. riparia. Methods: Petroleum ether (HRPE), Ethyl acetate (HREA), Butanol (HRBU), aqueous fractions (HRAQ) were prepared from the crude methanol extract of H. riparia (HRM) using liquid partitioning. Total phenolic content, flavonoid content and antioxidant activity assay were performed according to suitable methods. Nephroprotective activities were evaluated by MTT assay using Human Embryonic Kidney cells against cisplatin induced toxicity. Quantification of gallic acid was performed using validated HPTLC method. Results: The studies showed that extract and fractions possess significant nephroprotective activity against cisplatin induced renal toxicity. All the extracts/fractions of whole plant of Homonoia riparia was found to be significantly reducing cisplatin induced toxicity (< 0.05). The highest activity was observed with HRBU and HRAQ with a percentage viability of 293.09 ± 4.3 and 345.07 ± 3.2 at a concentration of 200 μg/ml. Gallic acid was detected in the HRM/fractions using HPTLC.

AB - Background: Homonoia riparia is a plant, which is widely used in the indigenous system of medicine for the treatment of urolithiasis, renal disorders and inflammatory conditions. This is the first report on the antioxidant and nephroprotective activities of whole plant of H. riparia. Objective: The present study aims at investigating the in vitro antioxidant and nephroprotective activity of the methanol extract and its different fractions of H. riparia. Methods: Petroleum ether (HRPE), Ethyl acetate (HREA), Butanol (HRBU), aqueous fractions (HRAQ) were prepared from the crude methanol extract of H. riparia (HRM) using liquid partitioning. Total phenolic content, flavonoid content and antioxidant activity assay were performed according to suitable methods. Nephroprotective activities were evaluated by MTT assay using Human Embryonic Kidney cells against cisplatin induced toxicity. Quantification of gallic acid was performed using validated HPTLC method. Results: The studies showed that extract and fractions possess significant nephroprotective activity against cisplatin induced renal toxicity. All the extracts/fractions of whole plant of Homonoia riparia was found to be significantly reducing cisplatin induced toxicity (< 0.05). The highest activity was observed with HRBU and HRAQ with a percentage viability of 293.09 ± 4.3 and 345.07 ± 3.2 at a concentration of 200 μg/ml. Gallic acid was detected in the HRM/fractions using HPTLC.

UR - http://www.scopus.com/inward/record.url?scp=85009786116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009786116&partnerID=8YFLogxK

U2 - 10.4103/0973-1296.197647

DO - 10.4103/0973-1296.197647

M3 - Article

VL - 13

SP - 25

EP - 30

JO - Pharmacognosy Magazine

JF - Pharmacognosy Magazine

SN - 0973-1296

IS - 49

ER -